C

Celon Pharma SA
WSE:CLN

Watchlist Manager
Celon Pharma SA
WSE:CLN
Watchlist
Price: 25.05 PLN 0.2% Market Closed
Market Cap: 1.3B PLN
Have any thoughts about
Celon Pharma SA?
Write Note

Celon Pharma SA
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Celon Pharma SA
Interest Income Expense Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
C
Celon Pharma SA
WSE:CLN
Interest Income Expense
-zł691k
CAGR 3-Years
40%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Molecure SA
WSE:MOC
Interest Income Expense
zł3.5m
CAGR 3-Years
N/A
CAGR 5-Years
38%
CAGR 10-Years
N/A
C
Cannabis Poland SA
WSE:CBD
Interest Income Expense
zł116.3k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Celon Pharma SA
Glance View

Market Cap
1.3B PLN
Industry
Pharmaceuticals

Celon Pharma SA is a pharmaceutical company, which engages in the research and manufacture of modern drugs. The firm focuses on research, development and production of generic drugs for cancer, neurological diseases, diabetes and other metabolic disorders treatment, among others. Its products portfolio comprises pills, such as Aromek, Bosentan Celon, Donepex, Ketrel, Lazivir and Valzek, as well as inhalation powder, such as Salmex. The firm's research center develops pharmaceuticals within a number of therapeutic areas, including oncology, neurology, as well as inflammatory and metabolic diseases. The firm is a subsidiary of Glatton sp z o o.

CLN Intrinsic Value
9.71 PLN
Overvaluation 61%
Intrinsic Value
Price
C

See Also

What is Celon Pharma SA's Interest Income Expense?
Interest Income Expense
-691k PLN

Based on the financial report for Jun 30, 2024, Celon Pharma SA's Interest Income Expense amounts to -691k PLN.

What is Celon Pharma SA's Interest Income Expense growth rate?
Interest Income Expense CAGR 3Y
40%

The average annual Interest Income Expense growth rates for Celon Pharma SA have been 40% over the past three years .

Back to Top